The global Influenza Therapeutics market is projected to grow from US$ 7186.5 million in 2024 to US$ 9521.1 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.8% during the forecast period.

Influenza Therapeutics Market

Influenza, commonly known as the flu, is an infectious disease caused by an influenza virus.

Market Analysis and Insights: Global Influenza Therapeutics Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Influenza Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Influenza Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Influenza Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Influenza Therapeutics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Influenza Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Influenza Therapeutics revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Influenza Therapeutics Market Report

Report Metric	Details
Report Name	Influenza Therapeutics Market
Accounted market size in 2024	US$ 7186.5 million
Forecasted market size in 2030	US$ 9521.1 million
CAGR	4.8
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	Vaccines Drugs
Segment by Application	Hospitals Clinic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott Laboratories, Astrazeneca PLC, Biocryst Pharmaceuticals, Inc., Chiron Corporation, CSL Limited, Daiichi Sankyo Co., Ltd., Glaxosmithkline PLC, Mitsubishi Tanabe Pharma Corporation, Nanotherapeutics Inc., Protein Sciences Corporation, Roche Holding AG, Sanofi SA, Shionogi & Co., Ltd., Sinovac Biotech Ltd.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Influenza Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Influenza Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Influenza Therapeutics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Influenza Therapeutics Market growing?

Ans: The Influenza Therapeutics Market witnessing a CAGR of 4.8 during the forecast period 2025-2030.

What is the Influenza Therapeutics Market size in 2030?

Ans: The Influenza Therapeutics Market size in 2030 will be US$ 9521.1 million.

Who are the main players in the Influenza Therapeutics Market report?

Ans: The main players in the Influenza Therapeutics Market are Abbott Laboratories, Astrazeneca PLC, Biocryst Pharmaceuticals, Inc., Chiron Corporation, CSL Limited, Daiichi Sankyo Co., Ltd., Glaxosmithkline PLC, Mitsubishi Tanabe Pharma Corporation, Nanotherapeutics Inc., Protein Sciences Corporation, Roche Holding AG, Sanofi SA, Shionogi & Co., Ltd., Sinovac Biotech Ltd.

What are the Application segmentation covered in the Influenza Therapeutics Market report?

Ans: The Applications covered in the Influenza Therapeutics Market report are Hospitals, Clinic, Others

What are the Type segmentation covered in the Influenza Therapeutics Market report?

Ans: The Types covered in the Influenza Therapeutics Market report are Vaccines, Drugs

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Influenza Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Vaccines

1.2.3 Drugs

1.3 Market by Application

1.3.1 Global Influenza Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Clinic

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Influenza Therapeutics Market Perspective (2019-2030)

2.2 Global Influenza Therapeutics Growth Trends by Region

2.2.1 Influenza Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Influenza Therapeutics Historic Market Size by Region (2019-2024)

2.2.3 Influenza Therapeutics Forecasted Market Size by Region (2025-2030)

2.3 Influenza Therapeutics Market Dynamics

2.3.1 Influenza Therapeutics Industry Trends

2.3.2 Influenza Therapeutics Market Drivers

2.3.3 Influenza Therapeutics Market Challenges

2.3.4 Influenza Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Influenza Therapeutics by Players

3.1.1 Global Influenza Therapeutics Revenue by Players (2019-2024)

3.1.2 Global Influenza Therapeutics Revenue Market Share by Players (2019-2024)

3.2 Global Influenza Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Influenza Therapeutics, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Influenza Therapeutics Market Concentration Ratio

3.4.1 Global Influenza Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Influenza Therapeutics Revenue in 2023

3.5 Global Key Players of Influenza Therapeutics Head office and Area Served

3.6 Global Key Players of Influenza Therapeutics, Product and Application

3.7 Global Key Players of Influenza Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Influenza Therapeutics Breakdown Data by Type

4.1 Global Influenza Therapeutics Historic Market Size by Type (2019-2024)

4.2 Global Influenza Therapeutics Forecasted Market Size by Type (2025-2030)

5 Influenza Therapeutics Breakdown Data by Application

5.1 Global Influenza Therapeutics Historic Market Size by Application (2019-2024)

5.2 Global Influenza Therapeutics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Influenza Therapeutics Market Size (2019-2030)

6.2 North America Influenza Therapeutics Market Size by Type

6.2.1 North America Influenza Therapeutics Market Size by Type (2019-2024)

6.2.2 North America Influenza Therapeutics Market Size by Type (2025-2030)

6.2.3 North America Influenza Therapeutics Market Share by Type (2019-2030)

6.3 North America Influenza Therapeutics Market Size by Application

6.3.1 North America Influenza Therapeutics Market Size by Application (2019-2024)

6.3.2 North America Influenza Therapeutics Market Size by Application (2025-2030)

6.3.3 North America Influenza Therapeutics Market Share by Application (2019-2030)

6.4 North America Influenza Therapeutics Market Size by Country

6.4.1 North America Influenza Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Influenza Therapeutics Market Size by Country (2019-2024)

6.4.3 North America Influenza Therapeutics Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Influenza Therapeutics Market Size (2019-2030)

7.2 Europe Influenza Therapeutics Market Size by Type

7.2.1 Europe Influenza Therapeutics Market Size by Type (2019-2024)

7.2.2 Europe Influenza Therapeutics Market Size by Type (2025-2030)

7.2.3 Europe Influenza Therapeutics Market Share by Type (2019-2030)

7.3 Europe Influenza Therapeutics Market Size by Application

7.3.1 Europe Influenza Therapeutics Market Size by Application (2019-2024)

7.3.2 Europe Influenza Therapeutics Market Size by Application (2025-2030)

7.3.3 Europe Influenza Therapeutics Market Share by Application (2019-2030)

7.4 Europe Influenza Therapeutics Market Size by Country

7.4.1 Europe Influenza Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Influenza Therapeutics Market Size by Country (2019-2024)

7.4.3 Europe Influenza Therapeutics Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Influenza Therapeutics Market Size (2019-2030)

8.2 China Influenza Therapeutics Market Size by Type

8.2.1 China Influenza Therapeutics Market Size by Type (2019-2024)

8.2.2 China Influenza Therapeutics Market Size by Type (2025-2030)

8.2.3 China Influenza Therapeutics Market Share by Type (2019-2030)

8.3 China Influenza Therapeutics Market Size by Application

8.3.1 China Influenza Therapeutics Market Size by Application (2019-2024)

8.3.2 China Influenza Therapeutics Market Size by Application (2025-2030)

8.3.3 China Influenza Therapeutics Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Influenza Therapeutics Market Size (2019-2030)

9.2 Asia Influenza Therapeutics Market Size by Type

9.2.1 Asia Influenza Therapeutics Market Size by Type (2019-2024)

9.2.2 Asia Influenza Therapeutics Market Size by Type (2025-2030)

9.2.3 Asia Influenza Therapeutics Market Share by Type (2019-2030)

9.3 Asia Influenza Therapeutics Market Size by Application

9.3.1 Asia Influenza Therapeutics Market Size by Application (2019-2024)

9.3.2 Asia Influenza Therapeutics Market Size by Application (2025-2030)

9.3.3 Asia Influenza Therapeutics Market Share by Application (2019-2030)

9.4 Asia Influenza Therapeutics Market Size by Region

9.4.1 Asia Influenza Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Influenza Therapeutics Market Size by Region (2019-2024)

9.4.3 Asia Influenza Therapeutics Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Influenza Therapeutics Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Influenza Therapeutics Market Size by Type

10.2.1 Middle East, Africa, and Latin America Influenza Therapeutics Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Influenza Therapeutics Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Influenza Therapeutics Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Influenza Therapeutics Market Size by Application

10.3.1 Middle East, Africa, and Latin America Influenza Therapeutics Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Influenza Therapeutics Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Influenza Therapeutics Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Influenza Therapeutics Market Size by Country

10.4.1 Middle East, Africa, and Latin America Influenza Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Influenza Therapeutics Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Influenza Therapeutics Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Abbott Laboratories

11.1.1 Abbott Laboratories Company Details

11.1.2 Abbott Laboratories Business Overview

11.1.3 Abbott Laboratories Influenza Therapeutics Introduction

11.1.4 Abbott Laboratories Revenue in Influenza Therapeutics Business (2019-2024)

11.1.5 Abbott Laboratories Recent Developments

11.2 Astrazeneca PLC

11.2.1 Astrazeneca PLC Company Details

11.2.2 Astrazeneca PLC Business Overview

11.2.3 Astrazeneca PLC Influenza Therapeutics Introduction

11.2.4 Astrazeneca PLC Revenue in Influenza Therapeutics Business (2019-2024)

11.2.5 Astrazeneca PLC Recent Developments

11.3 Biocryst Pharmaceuticals, Inc.

11.3.1 Biocryst Pharmaceuticals, Inc. Company Details

11.3.2 Biocryst Pharmaceuticals, Inc. Business Overview

11.3.3 Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Introduction

11.3.4 Biocryst Pharmaceuticals, Inc. Revenue in Influenza Therapeutics Business (2019-2024)

11.3.5 Biocryst Pharmaceuticals, Inc. Recent Developments

11.4 Chiron Corporation

11.4.1 Chiron Corporation Company Details

11.4.2 Chiron Corporation Business Overview

11.4.3 Chiron Corporation Influenza Therapeutics Introduction

11.4.4 Chiron Corporation Revenue in Influenza Therapeutics Business (2019-2024)

11.4.5 Chiron Corporation Recent Developments

11.5 CSL Limited

11.5.1 CSL Limited Company Details

11.5.2 CSL Limited Business Overview

11.5.3 CSL Limited Influenza Therapeutics Introduction

11.5.4 CSL Limited Revenue in Influenza Therapeutics Business (2019-2024)

11.5.5 CSL Limited Recent Developments

11.6 Daiichi Sankyo Co., Ltd.

11.6.1 Daiichi Sankyo Co., Ltd. Company Details

11.6.2 Daiichi Sankyo Co., Ltd. Business Overview

11.6.3 Daiichi Sankyo Co., Ltd. Influenza Therapeutics Introduction

11.6.4 Daiichi Sankyo Co., Ltd. Revenue in Influenza Therapeutics Business (2019-2024)

11.6.5 Daiichi Sankyo Co., Ltd. Recent Developments

11.7 Glaxosmithkline PLC

11.7.1 Glaxosmithkline PLC Company Details

11.7.2 Glaxosmithkline PLC Business Overview

11.7.3 Glaxosmithkline PLC Influenza Therapeutics Introduction

11.7.4 Glaxosmithkline PLC Revenue in Influenza Therapeutics Business (2019-2024)

11.7.5 Glaxosmithkline PLC Recent Developments

11.8 Mitsubishi Tanabe Pharma Corporation

11.8.1 Mitsubishi Tanabe Pharma Corporation Company Details

11.8.2 Mitsubishi Tanabe Pharma Corporation Business Overview

11.8.3 Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Introduction

11.8.4 Mitsubishi Tanabe Pharma Corporation Revenue in Influenza Therapeutics Business (2019-2024)

11.8.5 Mitsubishi Tanabe Pharma Corporation Recent Developments

11.9 Nanotherapeutics Inc.

11.9.1 Nanotherapeutics Inc. Company Details

11.9.2 Nanotherapeutics Inc. Business Overview

11.9.3 Nanotherapeutics Inc. Influenza Therapeutics Introduction

11.9.4 Nanotherapeutics Inc. Revenue in Influenza Therapeutics Business (2019-2024)

11.9.5 Nanotherapeutics Inc. Recent Developments

11.10 Protein Sciences Corporation

11.10.1 Protein Sciences Corporation Company Details

11.10.2 Protein Sciences Corporation Business Overview

11.10.3 Protein Sciences Corporation Influenza Therapeutics Introduction

11.10.4 Protein Sciences Corporation Revenue in Influenza Therapeutics Business (2019-2024)

11.10.5 Protein Sciences Corporation Recent Developments

11.11 Roche Holding AG

11.11.1 Roche Holding AG Company Details

11.11.2 Roche Holding AG Business Overview

11.11.3 Roche Holding AG Influenza Therapeutics Introduction

11.11.4 Roche Holding AG Revenue in Influenza Therapeutics Business (2019-2024)

11.11.5 Roche Holding AG Recent Developments

11.12 Sanofi SA

11.12.1 Sanofi SA Company Details

11.12.2 Sanofi SA Business Overview

11.12.3 Sanofi SA Influenza Therapeutics Introduction

11.12.4 Sanofi SA Revenue in Influenza Therapeutics Business (2019-2024)

11.12.5 Sanofi SA Recent Developments

11.13 Shionogi & Co., Ltd.

11.13.1 Shionogi & Co., Ltd. Company Details

11.13.2 Shionogi & Co., Ltd. Business Overview

11.13.3 Shionogi & Co., Ltd. Influenza Therapeutics Introduction

11.13.4 Shionogi & Co., Ltd. Revenue in Influenza Therapeutics Business (2019-2024)

11.13.5 Shionogi & Co., Ltd. Recent Developments

11.14 Sinovac Biotech Ltd.

11.14.1 Sinovac Biotech Ltd. Company Details

11.14.2 Sinovac Biotech Ltd. Business Overview

11.14.3 Sinovac Biotech Ltd. Influenza Therapeutics Introduction

11.14.4 Sinovac Biotech Ltd. Revenue in Influenza Therapeutics Business (2019-2024)

11.14.5 Sinovac Biotech Ltd. Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Abbott Laboratories

Astrazeneca plc

BioCryst Pharmaceuticals Inc

Chiron Corporation

CSL Limited

Daiichi Sankyo Co Ltd

GlaxoSmithKline PLC

Mitsubishi Tanabe Pharma Corporation

Nanotherapeutics Inc

Protein Sciences Corporation

List of Tables

Table 1. Global Influenza Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Vaccines

Table 3. Key Players of Drugs

Table 4. Global Influenza Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 5. Global Influenza Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Influenza Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Influenza Therapeutics Market Share by Region (2019-2024)

Table 8. Global Influenza Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Influenza Therapeutics Market Share by Region (2025-2030)

Table 10. Influenza Therapeutics Market Trends

Table 11. Influenza Therapeutics Market Drivers

Table 12. Influenza Therapeutics Market Challenges

Table 13. Influenza Therapeutics Market Restraints

Table 14. Global Influenza Therapeutics Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Influenza Therapeutics Revenue Share by Players (2019-2024)

Table 16. Global Top Influenza Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Therapeutics as of 2023)

Table 17. Global Influenza Therapeutics Industry Ranking 2022 VS 2023 VS 2024

Table 18. Global 5 Largest Players Market Share by Influenza Therapeutics Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of Influenza Therapeutics, Headquarters and Area Served

Table 20. Global Key Players of Influenza Therapeutics, Product and Application

Table 21. Global Key Players of Influenza Therapeutics, Product and Application

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Influenza Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Influenza Therapeutics Revenue Market Share by Type (2019-2024)

Table 25. Global Influenza Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Influenza Therapeutics Revenue Market Share by Type (2025-2030)

Table 27. Global Influenza Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Influenza Therapeutics Revenue Share by Application (2019-2024)

Table 29. Global Influenza Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Influenza Therapeutics Revenue Share by Application (2025-2030)

Table 31. North America Influenza Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 32. North America Influenza Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 33. North America Influenza Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 34. North America Influenza Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 35. North America Influenza Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Influenza Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Influenza Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Influenza Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 39. Europe Influenza Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 40. Europe Influenza Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 41. Europe Influenza Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 42. Europe Influenza Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Europe Influenza Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 44. Europe Influenza Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 45. China Influenza Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 46. China Influenza Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 47. China Influenza Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 48. China Influenza Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 49. Asia Influenza Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 50. Asia Influenza Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 51. Asia Influenza Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 52. Asia Influenza Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 53. Asia Influenza Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 54. Asia Influenza Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 55. Asia Influenza Therapeutics Market Size by Region (2025-2030) & (US$ Million)

Table 56. Middle East, Africa, and Latin America Influenza Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Influenza Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Influenza Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Influenza Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Influenza Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 61. Middle East, Africa, and Latin America Influenza Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Influenza Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 63. Abbott Laboratories Company Details

Table 64. Abbott Laboratories Business Overview

Table 65. Abbott Laboratories Influenza Therapeutics Product

Table 66. Abbott Laboratories Revenue in Influenza Therapeutics Business (2019-2024) & (US$ Million)

Table 67. Abbott Laboratories Recent Developments

Table 68. Astrazeneca PLC Company Details

Table 69. Astrazeneca PLC Business Overview

Table 70. Astrazeneca PLC Influenza Therapeutics Product

Table 71. Astrazeneca PLC Revenue in Influenza Therapeutics Business (2019-2024) & (US$ Million)

Table 72. Astrazeneca PLC Recent Developments

Table 73. Biocryst Pharmaceuticals, Inc. Company Details

Table 74. Biocryst Pharmaceuticals, Inc. Business Overview

Table 75. Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Product

Table 76. Biocryst Pharmaceuticals, Inc. Revenue in Influenza Therapeutics Business (2019-2024) & (US$ Million)

Table 77. Biocryst Pharmaceuticals, Inc. Recent Developments

Table 78. Chiron Corporation Company Details

Table 79. Chiron Corporation Business Overview

Table 80. Chiron Corporation Influenza Therapeutics Product

Table 81. Chiron Corporation Revenue in Influenza Therapeutics Business (2019-2024) & (US$ Million)

Table 82. Chiron Corporation Recent Developments

Table 83. CSL Limited Company Details

Table 84. CSL Limited Business Overview

Table 85. CSL Limited Influenza Therapeutics Product

Table 86. CSL Limited Revenue in Influenza Therapeutics Business (2019-2024) & (US$ Million)

Table 87. CSL Limited Recent Developments

Table 88. Daiichi Sankyo Co., Ltd. Company Details

Table 89. Daiichi Sankyo Co., Ltd. Business Overview

Table 90. Daiichi Sankyo Co., Ltd. Influenza Therapeutics Product

Table 91. Daiichi Sankyo Co., Ltd. Revenue in Influenza Therapeutics Business (2019-2024) & (US$ Million)

Table 92. Daiichi Sankyo Co., Ltd. Recent Developments

Table 93. Glaxosmithkline PLC Company Details

Table 94. Glaxosmithkline PLC Business Overview

Table 95. Glaxosmithkline PLC Influenza Therapeutics Product

Table 96. Glaxosmithkline PLC Revenue in Influenza Therapeutics Business (2019-2024) & (US$ Million)

Table 97. Glaxosmithkline PLC Recent Developments

Table 98. Mitsubishi Tanabe Pharma Corporation Company Details

Table 99. Mitsubishi Tanabe Pharma Corporation Business Overview

Table 100. Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Product

Table 101. Mitsubishi Tanabe Pharma Corporation Revenue in Influenza Therapeutics Business (2019-2024) & (US$ Million)

Table 102. Mitsubishi Tanabe Pharma Corporation Recent Developments

Table 103. Nanotherapeutics Inc. Company Details

Table 104. Nanotherapeutics Inc. Business Overview

Table 105. Nanotherapeutics Inc. Influenza Therapeutics Product

Table 106. Nanotherapeutics Inc. Revenue in Influenza Therapeutics Business (2019-2024) & (US$ Million)

Table 107. Nanotherapeutics Inc. Recent Developments

Table 108. Protein Sciences Corporation Company Details

Table 109. Protein Sciences Corporation Business Overview

Table 110. Protein Sciences Corporation Influenza Therapeutics Product

Table 111. Protein Sciences Corporation Revenue in Influenza Therapeutics Business (2019-2024) & (US$ Million)

Table 112. Protein Sciences Corporation Recent Developments

Table 113. Roche Holding AG Company Details

Table 114. Roche Holding AG Business Overview

Table 115. Roche Holding AG Influenza Therapeutics Product

Table 116. Roche Holding AG Revenue in Influenza Therapeutics Business (2019-2024) & (US$ Million)

Table 117. Roche Holding AG Recent Developments

Table 118. Sanofi SA Company Details

Table 119. Sanofi SA Business Overview

Table 120. Sanofi SA Influenza Therapeutics Product

Table 121. Sanofi SA Revenue in Influenza Therapeutics Business (2019-2024) & (US$ Million)

Table 122. Sanofi SA Recent Developments

Table 123. Shionogi & Co., Ltd. Company Details

Table 124. Shionogi & Co., Ltd. Business Overview

Table 125. Shionogi & Co., Ltd. Influenza Therapeutics Product

Table 126. Shionogi & Co., Ltd. Revenue in Influenza Therapeutics Business (2019-2024) & (US$ Million)

Table 127. Shionogi & Co., Ltd. Recent Developments

Table 128. Sinovac Biotech Ltd. Company Details

Table 129. Sinovac Biotech Ltd. Business Overview

Table 130. Sinovac Biotech Ltd. Influenza Therapeutics Product

Table 131. Sinovac Biotech Ltd. Revenue in Influenza Therapeutics Business (2019-2024) & (US$ Million)

Table 132. Sinovac Biotech Ltd. Recent Developments

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Influenza Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Influenza Therapeutics Market Share by Type: 2023 VS 2030

Figure 3. Vaccines Features

Figure 4. Drugs Features

Figure 5. Global Influenza Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 6. Global Influenza Therapeutics Market Share by Application: 2023 VS 2030

Figure 7. Hospitals Case Studies

Figure 8. Clinic Case Studies

Figure 9. Others Case Studies

Figure 10. Influenza Therapeutics Report Years Considered

Figure 11. Global Influenza Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Influenza Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Influenza Therapeutics Market Share by Region: 2023 VS 2030

Figure 14. Global Influenza Therapeutics Market Share by Players in 2023

Figure 15. Global Top Influenza Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Therapeutics as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Influenza Therapeutics Revenue in 2023

Figure 17. North America Influenza Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Influenza Therapeutics Market Share by Type (2019-2030)

Figure 19. North America Influenza Therapeutics Market Share by Application (2019-2030)

Figure 20. North America Influenza Therapeutics Market Share by Country (2019-2030)

Figure 21. United States Influenza Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Influenza Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Influenza Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 24. Europe Influenza Therapeutics Market Share by Type (2019-2030)

Figure 25. Europe Influenza Therapeutics Market Share by Application (2019-2030)

Figure 26. Europe Influenza Therapeutics Market Share by Country (2019-2030)

Figure 27. Germany Influenza Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Influenza Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Influenza Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Influenza Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Influenza Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Influenza Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. China Influenza Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 34. China Influenza Therapeutics Market Share by Type (2019-2030)

Figure 35. China Influenza Therapeutics Market Share by Application (2019-2030)

Figure 36. Asia Influenza Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 37. Asia Influenza Therapeutics Market Share by Type (2019-2030)

Figure 38. Asia Influenza Therapeutics Market Share by Application (2019-2030)

Figure 39. Asia Influenza Therapeutics Market Share by Region (2019-2030)

Figure 40. Japan Influenza Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. South Korea Influenza Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. China Taiwan Influenza Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Southeast Asia Influenza Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. India Influenza Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Australia Influenza Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East, Africa, and Latin America Influenza Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Influenza Therapeutics Market Share by Type (2019-2030)

Figure 48. Middle East, Africa, and Latin America Influenza Therapeutics Market Share by Application (2019-2030)

Figure 49. Middle East, Africa, and Latin America Influenza Therapeutics Market Share by Country (2019-2030)

Figure 50. Brazil Influenza Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Mexico Influenza Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Turkey Influenza Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Saudi Arabia Influenza Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Israel Influenza Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. GCC Countries Influenza Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Abbott Laboratories Revenue Growth Rate in Influenza Therapeutics Business (2019-2024)

Figure 57. Astrazeneca PLC Revenue Growth Rate in Influenza Therapeutics Business (2019-2024)

Figure 58. Biocryst Pharmaceuticals, Inc. Revenue Growth Rate in Influenza Therapeutics Business (2019-2024)

Figure 59. Chiron Corporation Revenue Growth Rate in Influenza Therapeutics Business (2019-2024)

Figure 60. CSL Limited Revenue Growth Rate in Influenza Therapeutics Business (2019-2024)

Figure 61. Daiichi Sankyo Co., Ltd. Revenue Growth Rate in Influenza Therapeutics Business (2019-2024)

Figure 62. Glaxosmithkline PLC Revenue Growth Rate in Influenza Therapeutics Business (2019-2024)

Figure 63. Mitsubishi Tanabe Pharma Corporation Revenue Growth Rate in Influenza Therapeutics Business (2019-2024)

Figure 64. Nanotherapeutics Inc. Revenue Growth Rate in Influenza Therapeutics Business (2019-2024)

Figure 65. Protein Sciences Corporation Revenue Growth Rate in Influenza Therapeutics Business (2019-2024)

Figure 66. Roche Holding AG Revenue Growth Rate in Influenza Therapeutics Business (2019-2024)

Figure 67. Sanofi SA Revenue Growth Rate in Influenza Therapeutics Business (2019-2024)

Figure 68. Shionogi & Co., Ltd. Revenue Growth Rate in Influenza Therapeutics Business (2019-2024)

Figure 69. Sinovac Biotech Ltd. Revenue Growth Rate in Influenza Therapeutics Business (2019-2024)

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Helicobacter Pylori Test Kit Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-27S9781

Tue Feb 18 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Infectious Diseases Molecular Diagnostics Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10K9685

Tue Feb 18 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Angio Seal Devices Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-21N10613

Mon Feb 17 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Vaccine Syringes Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19K10622

Mon Feb 17 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions